A game changing AI tool that will have the unique ability of predicting if a clinical-stage drug candidate will achieve regulatory approval.  This yields real-time ability to restructure clinical trial protocols, go/no-go investment decisions, optimizing R&D costs and commercial viability assessment.

The streamlined & more succinct version of our customized enterprise platform. An AI platform with real-time news and competitor updates, resulting in a lower cost, turnkey solution for Competitive Intelligence.

The first-to-market AI platform that will allow Market Access teams be competitive for determining rebate discounts, pricing & reimbursement and payer policies, all of which give a competitive advantage for optimizing gross-to-net (GTN) of either new-to-market products, or loss of exclusivity (LOE) products.